Micronase

Intended to relieve chronic blood sugar elevations to support endocrine balance and target pancreatic beta cells.

Dosage

Pack size

You will receive a quality generic equivalent of Micronase, depending on stock.

Prescription and consultation requirements for Micronase vary by destination and are determined by the fulfilment partner.

Micronase details

Condition: Type 2 Diabetes Mellitus
Alternative names: glyburide
Therapeutic class: Sulfonylurea
Pharmacological class: Antidiabetic
Contraindications: diabetic ketoacidosis; type 1 diabetes mellitus; severe hepatic impairment
Minor side effects: nausea; dizziness; headache
Moderate side effects: hypoglycaemia; weight gain; abdominal fullness
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Originator: Pfizer
Onset Time: 1–3 hours
Duration: 12–24 hours
Storage instructions: Store below 25°C.
Drug interactions: NSAIDs; Warfarin; Ciprofloxacin
Age restrictions: Approved for adults.

Serious side effects

severe hypoglycaemia, requires immediate medical attention; haemolytic anaemia, requires immediate medical attention

Patient summary

intended to relieve chronic blood sugar elevations to support endocrine balance and target pancreatic beta cells.

Mechanism of action

Binds to pancreatic ATP-sensitive potassium channels, causing depolarisation that stimulates endogenous insulin output.

Pregnancy and breastfeeding

TGA Category C: Use if potential benefits outweigh risks. Monitor newborn. Breastfeeding: Not recommended.

Micronase is the originator brand name, made by Pfizer. We use it to identify the medicine and are not affiliated with Pfizer.

The fulfilment partner confirms whether the exact brand or an equivalent containing Glibenclamide is offered.
The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
Check the final product details at checkout before confirming an order.